Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine, Killed Virus

Verify with FDA CVM →

68 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
68
Total Reports
7
Deaths Reported
1030.0%
Death Rate

Active Ingredients

Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine, Killed Virus

Administration Routes

SubcutaneousParenteralUnknown

Species Affected

Cat 68

Most Affected Breeds

Domestic Shorthair 51
Domestic Longhair 5
Domestic Mediumhair 4
Cat (unknown) 3
Maine Coon 2
Siamese 1
Cat (other) 1
Russian 1

Most Reported Reactions

Fever 23
Lethargy (see also Central nervous system depression in 'Neurological') 22
Not eating 20
Lethargy (see also Central nervous system depression in Neurological) 10
Vomiting 9
Injection site pain 8
Behavioural disorder NOS 8
Anorexia 7
Elevated temperature 6
Hiding 6
Pain NOS 6
Injection site swelling 5

Outcome Breakdown

Recovered/Normal
33 (48.5%)
Ongoing
16 (23.5%)
Outcome Unknown
12 (17.6%)
Died
4 (5.9%)
Euthanized
3 (4.4%)

Data Summary

Metric Value
Total adverse event reports 68
Reports involving death 7
Case-fatality rate (reported events) 1030.0%
Distinct species in reports 1
Distinct breeds in reports 8
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine, Killed Virus Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 68 adverse event reports referencing Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine, Killed Virus, including 7 reports in which the animal died — a 1030.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine, Killed Virus. Reported administration routes include Subcutaneous, Parenteral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine, Killed Virus reports are Cat (68 reports), with Cat accounting for the largest share. Within those species, Domestic Shorthair (51), Domestic Longhair (5), Domestic Mediumhair (4) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine, Killed Virus are Fever (23), Lethargy (see also Central nervous system depression in 'Neurological') (22), Not eating (20), Lethargy (see also Central nervous system depression in Neurological) (10). Of the 68 reports with a coded outcome, Recovered/Normal is the leading category at 48.5%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia Vaccine, Killed Virus.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial